comms@paragonbiosci.com

61 items

July 23, 2020

Synthetic Protein Design and Production Publication Confirms Evozyne’s Revolutionary Technology
Publication in peer-reviewed journal Science demonstrates the foundation [...]
June 3, 2020

Horizon Technology Finance and Emalex Biosciences Announce $15 Million Venture Loan Facility
– Biopharmaceutical company advancing clinical research evaluating novel [...]
May 19, 2020

Philadelphia Magazine features a Paragon portfolio company as a leader in cell and gene therapy innovation
May 19, 2020 – We are proud to share [...]
April 29, 2020

Congratulations to Harmony Biosciences for being ranked 8th on the Fortune Best Healthcare and Biopharma workplaces list
April 29, 2020 – Like all Paragon Biosciences companies, [...]
March 19, 2020

QuantX Artificial Intelligence Breast Cancer Diagnosis System Receives 2020 Gold Edison Award
The first FDA-cleared artificial intelligence diagnostic system for [...]
December 16, 2019

Castle Creek Pharmaceutical Holdings Completes Acquisition of Fibrocell Science
– Acquisition complements and expands Castle Creek [...]
August 19, 2019

Paragon Biosciences Announces the Formation of Paragon Health Capital
The newly created financial services organization was formed [...]
July 17, 2019

Paragon Biosciences Launches Qlarity Imaging to Advance the First FDA-Cleared Artificial Intelligence Breast Cancer Diagnosis System
The announcement signals accelerated access to more accurate [...]

Previous 567 Next